Abstract
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1007/s12325-023-02763-z
Journal: Advances in therapy | Publication Date: Feb 2, 2024 |
License type: CC BY-NC 4.0 |
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
Join us for a 30 min session where you can share your feedback and ask us any queries you have